Super-elderly Patients
Super-elderly Patients - Related Videos
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
0 Views •
Cited by 44 •
2017
'Super-selective' adrenal venous sampling (ssAVS, also called segmental adrenal venous sampling: sAVS) was performed using a micro-catheter to identify adrenal segment(s) that produce excessive amounts of hormones. The ssAVS technique was described, cases in which adrenal segmental lesion(s) were identified by ssAVS were presented, and the usefulness of ssAVS in future adrenal research was discussed.
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
0 Views •
2025
Overtreatment is often administered to patients with low-risk prostate cancer; super-active surveillance can help avoid such overtreatment.
08:47
Super-resolution Imaging of the Bacterial Division Machinery
0 Views •
Cited by 17 •
2013
We describe a super-resolution imaging method to probe the structural organization of the bacterial FtsZ-ring, an essential apparatus for cell division. This method is based on quantitative analyses of photoactivated localization microscopy (PALM) images and can be applied to other bacterial cytoskeletal proteins.
09:30
Super-resolution Imaging of Neuronal Dense-core Vesicles
0 Views •
Cited by 3 •
2014
We describe how to implement photoactivated localization microscopy (PALM)-based studies of vesicles in fixed, cultured neurons. Key components of our protocol include labeling vesicles with photoconvertible chimeras, collecting sparsely sampled raw images with a super-resolution microscopy system, and processing the raw images to produce a super-resolution image.
16:52
Test Samples for Optimizing STORM Super-Resolution Microscopy
0 Views •
Cited by 46 •
2013
We describe the preparation of three test samples and how they can be used to optimize and assess the performance of STORM microscopes. Using these examples we show how to acquire raw data and then process it to acquire super-resolution images in cells of approximately 30-50 nm resolution.
FAQs
Reduced physiological reserve can limit how well super-elderly patients tolerate illness, treatment, or other physiological demands. Age-related changes in organ function may also alter disease presentation and treatment response. Clinicians therefore weigh expected benefit against safety, functional effects, and quality of life rather than relying on disease management approaches that do not account for individual reserve.
Age-related changes in organ function can influence pharmacokinetics, the way the body absorbs, distributes, processes, and eliminates medicines. These changes may affect treatment response and medication safety, making medication selection and risk assessment especially important. Clinical decisions should consider the patient’s broader health status and other treatments rather than evaluating a medicine in isolation.
Multimorbidity, frailty, and cognitive impairment can create competing clinical priorities for super-elderly patients. A treatment that addresses one condition may need to be considered alongside overall function, safety, and quality of life. Recognizing these coexisting factors supports individualized assessment and helps clinicians make decisions that reflect the patient’s complete healthcare needs.
Assessment should consider age-related organ changes, physiological reserve, coexisting conditions, cognitive status, frailty, and current medication use. These factors can influence disease presentation, treatment response, and risk. Reviewing them together supports more individualized diagnosis and helps clinicians identify management options that balance potential benefits with safety and functional outcomes.
Medication selection should account for age-related changes in organ function and pharmacokinetics, as well as multimorbidity and polypharmacy. Clinicians must consider how treatments may affect safety, response, and overall function in the context of the patient’s other needs. This individualized approach supports risk assessment and more appropriate treatment decisions.
Shared decisions are especially important when treatment benefits must be balanced against safety, function, and quality of life. Super-elderly patients may have differing combinations of frailty, cognitive impairment, multimorbidity, and medication use, so a single approach may not fit everyone. Discussing these priorities helps align care with the patient’s circumstances and goals.
Research involving super-elderly patients helps clarify how advanced age affects disease presentation, treatment response, medication use, and healthcare needs. Findings can support refinement of geriatric care strategies and strengthen evidence-based management for later life. Including this population in research is therefore relevant to improving clinical decisions for people with complex age-related needs.